{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T09:53:47Z","timestamp":1780566827132,"version":"3.54.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100017065","name":"University of Michigan Medical Center Rogel Cancer Center","doi-asserted-by":"publisher","award":["P30CA46592"],"award-info":[{"award-number":["P30CA46592"]}],"id":[{"id":"10.13039\/100017065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA271799"],"award-info":[{"award-number":["R01CA271799"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DE031951"],"award-info":[{"award-number":["R01DE031951"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DK125087"],"award-info":[{"award-number":["R01DK125087"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DE026728"],"award-info":[{"award-number":["R01DE026728"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DE030691"],"award-info":[{"award-number":["R01DE030691"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS122536"],"award-info":[{"award-number":["R01NS122536"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jconrel.2025.114298","type":"journal-article","created":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:11:15Z","timestamp":1760195475000},"page":"114298","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"P1","title":["Remote loading of an autoantigen in PLGA nanoparticles for the treatment of multiple sclerosis"],"prefix":"10.1016","volume":"388","author":[{"given":"Corrine","family":"Din","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark Vander","family":"Roest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah E.","family":"Dobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl F.","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"April","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen H.","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Schwendeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven P.","family":"Schwendeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2025.114298_bb0005","series-title":"NIH triennial report: Fiscal years 2019, 2020, and 2021","author":"Health","year":"2023"},{"key":"10.1016\/j.jconrel.2025.114298_bb0010","author":"Sciences"},{"key":"10.1016\/j.jconrel.2025.114298_bb0015","author":"Stroke"},{"issue":"14","key":"10.1016\/j.jconrel.2025.114298_bb0020","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1177\/1352458520970841","article-title":"Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition","volume":"26","author":"Walton","year":"2020","journal-title":"Mult. Scler."},{"issue":"8","key":"10.1016\/j.jconrel.2025.114298_bb0025","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1001\/jama.2020.26858","article-title":"Diagnosis and treatment of multiple sclerosis: a review","volume":"325","author":"McGinley","year":"2021","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.jconrel.2025.114298_bb0030","doi-asserted-by":"crossref","first-page":"27","DOI":"10.5493\/wjem.v4.i3.27","article-title":"Multiple sclerosis and the role of immune cells","volume":"4","author":"H\u00f8glund","year":"2014","journal-title":"World J Exp Med"},{"issue":"4","key":"10.1016\/j.jconrel.2025.114298_bb0035","doi-asserted-by":"crossref","first-page":"175","DOI":"10.5415\/apallergy.0000000000000128","article-title":"Immunological mechanisms of tolerance: central, peripheral and the role of T and B cells","volume":"13","author":"Meng","year":"2023","journal-title":"Asia Pac. Allergy"},{"issue":"1","key":"10.1016\/j.jconrel.2025.114298_bb0040","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1600-065X.2011.01012.x","article-title":"Molecular mechanisms of T-cell tolerance","volume":"241","author":"Nurieva","year":"2011","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jconrel.2025.114298_bb0045","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2015.00322","article-title":"Antigen presentation, autoantigens, and immune regulation in multiple sclerosis and other autoimmune diseases","volume":"6","author":"Riedhammer","year":"2015","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114298_bb0050","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41565-020-00810-2","article-title":"Inducing immune tolerance with dendritic cell-targeting nanomedicines","volume":"16","author":"Cifuentes-Rius","year":"2021","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2025.114298_bb0055","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.744804","article-title":"Approaches to establishing tolerance in immune mediated diseases","volume":"12","author":"Huffaker","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2025.114298_bb0060","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1146\/annurev-pathol-052920-040318","article-title":"The immune response in multiple sclerosis","volume":"17","author":"Rodr\u00edguez Mur\u00faa","year":"2022","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.jconrel.2025.114298_bb0065","first-page":"261","article-title":"Fingolimod for multiple sclerosis and emerging indications: appropriate patient selection, safety precautions, and special considerations","volume":"12","author":"Ayzenberg","year":"2016","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.jconrel.2025.114298_bb0070","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.2147\/NDT.S114636","article-title":"The use of natalizumab for multiple sclerosis","volume":"13","author":"Brandstadter","year":"2017","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"11","key":"10.1016\/j.jconrel.2025.114298_bb0075","doi-asserted-by":"crossref","first-page":"4345","DOI":"10.1080\/21645515.2021.1969850","article-title":"Product review on MAbs (alemtuzumab and ocrelizumab) for the treatment of multiple sclerosis","volume":"17","author":"Gabeli\u0107","year":"2021","journal-title":"Hum. Vaccin. Immunother."},{"issue":"7","key":"10.1016\/j.jconrel.2025.114298_bb0080","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci7070078","article-title":"Multiple sclerosis: immunopathology and treatment update","volume":"7","author":"Dargahi","year":"2017","journal-title":"Brain Sci."},{"issue":"19","key":"10.1016\/j.jconrel.2025.114298_bb0085","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21197015","article-title":"Treg enhancing therapies to treat autoimmune diseases","volume":"21","author":"Eggenhuizen","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114298_bb0090","doi-asserted-by":"crossref","first-page":"ltab009","DOI":"10.1093\/immadv\/ltab009","article-title":"Advancement of antigen-specific immunotherapy: knowledge transfer between allergy and autoimmunity","volume":"1","author":"Richardson","year":"2021","journal-title":"Immunother Adv"},{"issue":"9","key":"10.1016\/j.jconrel.2025.114298_bb0095","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/nri2153","article-title":"Antigen-specific tolerance strategies for the prevention and treatment of autoimmune disease","volume":"7","author":"Miller","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2025.114298_bb0100","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.3389\/fimmu.2019.02393","article-title":"Induction of tolerance and immunity by dendritic cells: mechanisms and clinical applications","volume":"10","author":"Fucikova","year":"2019","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.jconrel.2025.114298_bb0105","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/ni.3331","article-title":"CD4(+) T cell anergy prevents autoimmunity and generates regulatory T cell precursors","volume":"17","author":"Kalekar","year":"2016","journal-title":"Nat. Immunol."},{"issue":"10","key":"10.1016\/j.jconrel.2025.114298_bb0110","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1084\/jem.20040249","article-title":"In vivo instruction of suppressor commitment in naive T cells","volume":"199","author":"Apostolou","year":"2004","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.jconrel.2025.114298_bb0115","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1365-3083.2009.02308.x","article-title":"How do regulatory T cells work?","volume":"70","author":"Corthay","year":"2009","journal-title":"Scand. J. Immunol."},{"issue":"5","key":"10.1016\/j.jconrel.2025.114298_bb0120","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.smim.2009.05.012","article-title":"CD40 and autoimmunity: the dark side of a great activator","volume":"21","author":"Peters","year":"2009","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.jconrel.2025.114298_bb0125","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.3389\/fimmu.2017.01791","article-title":"The CD40-CD40L dyad in experimental autoimmune encephalomyelitis and multiple sclerosis","volume":"8","author":"Aarts","year":"2017","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.jconrel.2025.114298_bb0130","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1021\/nn405033r","article-title":"A biodegradable nanoparticle platform for the induction of antigen-specific immune tolerance for treatment of autoimmune disease","volume":"8","author":"Hunter","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.114298_bb0135","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.biomaterials.2017.07.029","article-title":"An antigen-specific semi-therapeutic treatment with local delivery of tolerogenic factors through a dual-sized microparticle system blocks experimental autoimmune encephalomyelitis","volume":"143","author":"Cho","year":"2017","journal-title":"Biomaterials"},{"issue":"11","key":"10.1016\/j.jconrel.2025.114298_bb0140","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1016\/j.celrep.2016.08.033","article-title":"Reprogramming the local lymph node microenvironment promotes tolerance that is systemic and antigen specific","volume":"16","author":"Tostanoski","year":"2016","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114298_bb0145","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.1038\/s41467-022-30813-7","article-title":"Efficient aqueous remote loading of peptides in poly(lactic-co-glycolic acid)","volume":"13","author":"Giles","year":"2022","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114298_bb0150","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/eji.200324669","article-title":"Characterization of MHC- and TCR-binding residues of the myelin oligodendrocyte glycoprotein 38\u201351 peptide","volume":"34","author":"Petersen","year":"2004","journal-title":"Eur. J. Immunol."},{"issue":"2","key":"10.1016\/j.jconrel.2025.114298_bb0155","doi-asserted-by":"crossref","first-page":"E156","DOI":"10.1073\/pnas.1408686111","article-title":"Polymeric synthetic nanoparticles for the induction of antigen-specific immunological tolerance","volume":"112","author":"Maldonado","year":"2015","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114298_bb0160","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0022-1759(98)00204-X","article-title":"An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow","volume":"223","author":"Lutz","year":"1999","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jconrel.2025.114298_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119432","article-title":"Design of biodegradable nanoparticles to modulate phenotypes of antigen-presenting cells for antigen-specific treatment of autoimmune disease","volume":"222","author":"Saito","year":"2019","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.jconrel.2025.114298_bb0170","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.jconrel.2013.09.013","article-title":"Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles","volume":"172","author":"Ernsting","year":"2013","journal-title":"J. Control. Release"},{"issue":"9","key":"10.1016\/j.jconrel.2025.114298_bb0175","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nbt.3330","article-title":"Principles of nanoparticle design for overcoming biological barriers to drug delivery","volume":"33","author":"Blanco","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2025.114298_bb0180","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1146\/annurev.immunol.21.120601.141040","article-title":"Tolerogenic dendritic cells","volume":"21","author":"Steinman","year":"2003","journal-title":"Annu. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114298_bb0185","doi-asserted-by":"crossref","first-page":"52","DOI":"10.4110\/in.2016.16.1.52","article-title":"Generation of Tolerogenic dendritic cells and their therapeutic applications","volume":"16","author":"Yoo","year":"2016","journal-title":"Immune Netw."},{"issue":"27","key":"10.1016\/j.jconrel.2025.114298_bb0190","doi-asserted-by":"crossref","first-page":"9595","DOI":"10.1073\/pnas.0504131102","article-title":"Differential induction of IgE-mediated anaphylaxis after soluble vs. cell-bound tolerogenic peptide therapy of autoimmune encephalomyelitis","volume":"102","author":"Smith","year":"2005","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"7","key":"10.1016\/j.jconrel.2025.114298_bb0195","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1016\/j.ymthe.2017.03.032","article-title":"Peptide-conjugated nanoparticles reduce positive co-stimulatory expression and T cell activity to induce tolerance","volume":"25","author":"Kuo","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2025.114298_bb0200","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jconrel.2021.01.013","article-title":"PEGylation enables subcutaneously administered nanoparticles to induce antigen-specific immune tolerance","volume":"331","author":"Li","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114298_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122001","article-title":"Design principles of microparticle size and immunomodulatory factor formulation dictate antigen-specific amelioration of multiple sclerosis in a mouse model","volume":"294","author":"Kwiatkowski","year":"2023","journal-title":"Biomaterials"},{"issue":"43","key":"10.1016\/j.jconrel.2025.114298_bb0210","doi-asserted-by":"crossref","first-page":"5681","DOI":"10.1016\/j.vaccine.2014.08.016","article-title":"Subcutaneous inverse vaccination with PLGA particles loaded with a MOG peptide and IL-10 decreases the severity of experimental autoimmune encephalomyelitis","volume":"32","author":"Cappellano","year":"2014","journal-title":"Vaccine"},{"issue":"43","key":"10.1016\/j.jconrel.2025.114298_bb0215","doi-asserted-by":"crossref","first-page":"10800","DOI":"10.1002\/anie.201206387","article-title":"Self-healing microencapsulation of biomacromolecules without organic solvents","volume":"51","author":"Reinhold","year":"2012","journal-title":"Angew. Chem. Int. Ed. Eng."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925009113?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925009113?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T21:46:55Z","timestamp":1773179215000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925009113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":43,"alternative-id":["S0168365925009113"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114298","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Remote loading of an autoantigen in PLGA nanoparticles for the treatment of multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114298","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114298"}}